{
    "SPADE_UN_23808": {
        "Sequence Information": {
            "Peptide Name": "Hymenochirin-1B [D9K;E6,N10,A18,22 S-Fmoc-ALA-4-pen]",
            "Sequence": "IKLSPXTKKXLKKVLKGXIKGXIAVAKMV",
            "Sequence Length": 29,
            "Biological Activity": [
                "Anticancer"
            ],
            "Binding Target": "1. Lipid Bilayer",
            "Source": "",
            "Gene": "",
            "PDB ID": "",
            "UniProt Entry": [
                {
                    "uniprotId": "W8PRC4",
                    "uniprotUrl": "http://www.uniprot.org/uniprot/W8PRC4",
                    "description": "The amino acid sequence of the current peptide coincides with the part of the UniProt entry that may represent a peptide precursor."
                }
            ],
            "Literature": [
                {
                    "Title": "Improving Selectivity, Proteolytic Stability, and Antitumor Activity of Hymenochirin-1B: A Novel Glycosylated Staple Strategy.",
                    "Pubmed ID": "30789695",
                    "Reference": "ACS Chem Biol. 2019;14:516-525",
                    "Author": "Li Y, Zhang Y, Wu M, Chang Q, Hu H, Zhao X",
                    "URL": "http://www.ncbi.nlm.nih.gov/pubmed/30789695"
                }
            ],
            "SPADE ID": "SPADE_UN_23808",
            "Similar Sequences": [
                {
                    "SPADE_ID": "SPADE_UN_13418",
                    "Similarity": 1.0,
                    "Sequence": "IKLSPETKKNLKKVLKGAIKGAIAVAKMV"
                },
                {
                    "SPADE_ID": "SPADE_UN_13421",
                    "Similarity": 1.0,
                    "Sequence": "IKLSPKTKKNLKKVLKGAIKGAIAVAKMV"
                },
                {
                    "SPADE_ID": "SPADE_UN_13423",
                    "Similarity": 1.0,
                    "Sequence": "IKLSPETKKNLKKVLKGAIKGAIAVAKMV"
                }
            ],
            "Hemolytic Activity": "",
            "Target Organism": "Human lung carcinoma A549(IC50=2.10±0.32µM),Human colon adenocarcinoma HCT 116(IC50=2.63±0.35µM),Human hepatocellular carcinoma HepG2(IC50=4.93±0.53µM)"
        }
    }
}